Results

Premaitha - full year trading statement: BUY

Published 11 days ago

Premaitha (NIPT) has updated on trading in the year to March 31 2017. Of course, what matters is not historic trading but the future, that is to say the patent challenge by US corporate fascist bully-boys Ilumina. However, some numbers do matter...

Premaitha - puts Swiss distributor Genoma into bankruptcy: BUY

Published 16 days ago

The issue with Genoma was flagged up in the interims pre-Christmas. It owes Premaitha (NIPT) £750,000. That debt looks like a bad debt because the Swiss company has - despite its parent company concluding a fundraise - been having financial issues. So Premaitha has gone to court and had Genoma made bankrupt.

Premaitha - FY Results: numbers academic its the statement that counts: Buy

Published 232 days ago

Premaitha (NIPT) announced late last week its results for the year to March 31 2016. Given the pace of events here these historic numbers do not mean that much but for the record:

Premaitha - new loan facility - this is the start of more good news: Buy

Published 244 days ago

Apologies for the delay in commenting on this RNS which landed on Friday. We wanted to speak to Adam Reynolds and we have now done so. This is just the start of the good news and ahead of results tomorrow Premaitha (NIPT) shares are a buy.

Premaitha - God Bless the EU: Buy

Published 323 days ago

After 44 years of membership, at last one good thing has come out of the EU for Britain. God bless the Evil Empire. Premaitha (NIPT) has provided an update on its legal battles with US bully boys Illumina.

Premaitha - good news on patent dispute, the shares should double

Published 402 days ago

Although the twit who handles PR for Premaitha (NIPT) has again contrived to confuse the issue with some garbled press releases this morning there is actually some good news. Fire the idiot PR man and investors could get excited as they discover what is really going on.

Premaitha - all sorts of fun and games: buy

Published 410 days ago

The shares of Premaitha (NIPT) have been all over the shop since what was a cracking year end trading statement on Monday. The reason is the cackhanded disposal of Rupert Lywood's remaining 17.9% stake. We thought he was locked in following his last dump on 9 March and a statement signed off by broker Finncap. Weasel words. His shares were placed by Finncap at just 6.5p with directors taking some and solid institutions Helium, Henderson and Hargreave Hale taking the rest. The overhang is now gone but boy has it crushed the shares. Without Lywood's "assistance" since last summer we think the shares would be 20p today. But he is now out of the picture.

Premaitha contract wins & litigation timetable: buy

Published 484 days ago

Premaitha Health (NIPT) has announced further international expansion of its customer base and updated on UK litigation timing

Premaitha - Illumina are pests but the stance is buy

Published 506 days ago

Premaitha Health (NIPT) has noted an announcement from Illumina, Inc. of patent infringement suits against Premaitha's customer in Poland and Ariosa Diagnostics, a subsidiary of Roche, and their customer, The Doctors Laboratory, in the UK, while reiterating that it “continues to make a robust defence against earlier claims by Illumina and the board is confident that the IONA test does not infringe the patents as claimed in the earlier cases or in relation to today's announcement”


Tom Winnifrith's share tips of the year No 7 - Buy Premaitha at 18.5p - target 30p

Published 512 days ago

Ok this was one of my less successful share tips of the year for 2015 but this time it really will come good. That will be the prompt for guffaws of laughter from Wildes, who is currently sitting on a sinking lifeboat from the doomed SS LGO Energy. But he who laughs last... 

Premaitha - average down - buy

Published 596 days ago

Premaitha Health (NIPT) has announced an agreement with the leading distributor of scientific products in Greece (Antisel SA) to provide its IONA test to clinical laboratories in the region and that it has been informed that American company Illumina, Inc. has added a third patent to its suit against it. Buy, sell or hold?

ShareProphets

About ShareProphetsTerms of ServiceForgot My Password
Contact UsPrivacy PolicyForgot My Username
Advertise With UsCookie PolicyResend Account Validation Token
Send Us A Tip

Data by ADVFN / Site by Everywhen /